Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 29, Number 10—October 2023
Research

Sporadic Shiga Toxin–Producing Escherichia coli–Associated Pediatric Hemolytic Uremic Syndrome, France, 2012–2021

Gabrielle JonesComments to Author , Patricia Mariani-Kurkdjian, Aurélie Cointe, Stéphane Bonacorsi, Sophie Lefèvre, François-Xavier Weill, and Yann Le Strat
Author affiliations: Santé publique France, Saint-Maurice, France (G. Jones, Y. Le Strat); Centre Hospitalier Universitaire Robert Debré, Assistance publique–Hôpitaux de Paris, Paris, France (P. Mariani-Kurkdjian, A. Cointe, S. Bonacorsi); Institut Pasteur, Université Paris-Cité, Paris (S. Lefèvre, F.-X. Weill)

Main Article

Figure 3

Number of reported sporadic Shiga toxin–producing Escherichia coli–associated pediatric hemolytic uremic syndrome cases, by age group and sex, and incidence rate, by age group (black dots), France, 2012–2021. Data were missing on sex for 3 cases (1 case each in patients <1 year, 3 years, and 4 years of age).

Figure 3. Number of reported sporadic Shiga toxin–producing Escherichia coli–associated pediatric hemolytic uremic syndrome cases, by age group and sex, and incidence rate, by age group (black dots), France, 2012–2021. Data were missing on sex for 3 cases (1 case each in patients <1 year, 3 years, and 4 years of age).

Main Article

Page created: August 18, 2023
Page updated: September 20, 2023
Page reviewed: September 20, 2023
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external